The polyhedric reality of the interaction between COVID-19, asthma and inhaled corticosteroids

Francisco-Javier Gonzalez-Barcala; Juan-Jose Nieto-Fontarigo; Paula Mendez-Brea; Francisco-Javier Salgado

doi:10.1183/23120541.00179-2022

The polyhedric reality of the interaction between COVID-19, asthma and inhaled corticosteroids

ERJ Open Res. 2022 May 30;8(2):00179-2022. doi: 10.1183/23120541.00179-2022. eCollection 2022 Apr.

Authors

Francisco-Javier Gonzalez-Barcala^{1

2

3

4}, Juan-Jose Nieto-Fontarigo^{1

2

5}, Paula Mendez-Brea⁶, Francisco-Javier Salgado^{1

2

5}

Affiliations

¹ Translational Research In Airway Diseases Group (TRIAD), Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Santiago de Compostela, Spain.
² CIBER Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain.
³ Departamento de Medicina, Universidad de Santiago de Compostela, Santiago de Compostela, Spain.
⁴ Servicio de Neumología, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, Spain.
⁵ Departmento de Bioquímica y Biología Molecular, Facultad de Biología, Centro de Investigacións Biolóxicas (CIBUS), Universidade de Santiago de Compostela, Santiago de Compostela, Spain.
⁶ Servicio de Alergia, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, Spain.

Abstract

The impact of ICS on the prognosis for #COVID19 in #asthma patients requires a thorough evaluation of a range of factors that interact in this process, in order to draw solid conclusions, since at the present time the debate continues https://bit.ly/3xLNBrc.

Publication types

Editorial